A Study of B2065 in Patients With Acute Ischemic Stroke

Clinical trial NCT07371624 · RECRUITING

Trial details

NCT number: NCT07371624
Sponsor: Tasly Pharmaceutical Group Co., Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2025-12-31
Primary completion: 2027-12-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.